Emerald Advisers’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Emerald Advisers’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-973,776	Closed	-$4.58M	–	246
2023 Q2	$4.58M	Sell	973,776 -76,521	-7%	-$352K	0.2%	114
2023 Q1	$4.85M	Sell	1,050,297 -9,047	-0.9%	-$39.8K	0.23%	107
2022 Q4	$3.85M	Sell	1,059,344 -1,955	-0.2%	-$8.67K	0.19%	109
2022 Q3	$5.02M	Buy	1,061,299 +923	+0.1%	+$4.64K	0.26%	111
2022 Q2	$5.13M	Buy	1,060,376 +42,007	+4%	+$255K	0.26%	110
2022 Q1	$6.48M	Buy	1,018,369 +325,339	+47%	+$1.75M	0.25%	108
2021 Q4	$4.3M	Buy	693,030 +251,140	+57%	+$1.96M	0.16%	120
2021 Q3	$3.82M	Buy	+441,890	New	+$3.61M	0.14%	119

Other funds holding THRN

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Emerald Advisers's THRN Position: Q3 2023 in Review

Emerald Advisers sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q3 2023, closing a stake of 973,776 shares — an estimated $4.58M sold.

Emerald Advisers first reported a position in THRN in Q3 2021 and held it in 8 quarters. The position peaked at $6.48M in Q1 2022. 59 funds tracked by Wall St. Rank hold THRN as of Q3 2023.

Emerald Advisers reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Emerald Advisers sold 973,776 Thorne Healthtech, Inc. Common Stock shares in Q3 2023, an estimated $4.58M.
Emerald Advisers first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Emerald Advisers's Thorne Healthtech, Inc. Common Stock position peaked at $6.48M in Q1 2022.
59 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q3 2023.

Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.